Stockreport

Morphic appoints Simon Cooper as CMO [Seeking Alpha]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF Dr. Cooper most recently served as Chief Medical Officer of Keros Therapeutics. “Simon brings clinical development expertise stemming from leadership roles across the [Read more]